Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma

Phase 2

Conditions: Intracranial Germinoma

Interventions: Drug: Carboplatin
Drug: Etoposide
Drug: Cyclophosphamide
Drug: Bleomycin
Radiation: Reduced dose of radiotherapy

First Posted Date: 2016-05-25

Last Posted Date: 2016-05-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 40

Registration Number: NCT02782754

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Selective Lymph Node Dissection Using Fluorescent Dye in Node-positive Breast Cancer

Phase 4

Conditions: Breast Neoplasms

Interventions: Procedure: Axillary lymph node dissection
Drug: Indocyanine green
Device: Imaging devices

First Posted Date: 2016-05-24

Last Posted Date: 2016-09-20

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 150

Registration Number: NCT02781259

Locations: 🇰🇷
Samsung medical center, Seoul, Korea, Republic of

Response-based Treatment of High-risk Neuroblastoma

Phase 2

Conditions: Newly Diagnosed High Risk Neuroblastoma

Interventions: Drug: Cisplatin
Drug: Doxorubicin
Drug: Etoposide
Drug: Cyclophosphamide
Drug: Ifosfamide
Drug: Carboplatin
Procedure: Tandem HDCT/auto-SCT
Radiation: Radiotherapy
Drug: Interleukin-2
Drug: Isotretinoin
Radiation: MIBG

First Posted Date: 2016-05-13

Last Posted Date: 2016-05-24

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 54

Registration Number: NCT02771743

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Effects of Cerebrolysin Combined With Rehabilitation on Motor Recovery in Stroke

Phase 4

Completed

Conditions: Stroke

Interventions: Drug: Placebo
Drug: Cerebrolysin

First Posted Date: 2016-05-11

Last Posted Date: 2019-09-20

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 80

Registration Number: NCT02768571

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Comparison of Femoral Tunnel and Clinical Outcome Using Two Anterior Cruciate Ligament Reconstruction Techniques

Not Applicable

Completed

Conditions: Rupture of Anterior Cruciate Ligament

Interventions: Procedure: type of anterior cruciate ligament reconstruction

First Posted Date: 2016-04-28

Last Posted Date: 2019-12-20

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 67

Registration Number: NCT02754674

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Effect of Pravastatin in the Subjects With Prediabetes or Early Diabetes

Phase 4

Completed

Conditions: Prediabetic State
Diabetes Mellitus

Interventions: Behavioral: Nutritional education only
Drug: Placebo (for Pravastatin)
Drug: Pravastatin

First Posted Date: 2016-04-28

Last Posted Date: 2018-09-13

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 44

Registration Number: NCT02754739

Locations: 🇰🇷
Division of Endocrinology and Metabolism, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of

Development of Novel Strategy for Treatment of Anterior Cruciate Ligament (ACL) Injury Using Stem Cell

Not Applicable

Completed

Conditions: Deficiency of Anterior Cruciate Ligament

Interventions: Procedure: ACL reconstruction only
Biological: hyaluronic acid
Biological: Cartistem(TM)

First Posted Date: 2016-04-28

Last Posted Date: 2019-04-10

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 30

Registration Number: NCT02755376

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib

Phase 2

Completed

Conditions: Non-small Cell Lung Cancer

Interventions: Drug: Gilotrif

First Posted Date: 2016-04-22

Last Posted Date: 2021-03-19

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 50

Registration Number: NCT02747953

Isoniazid Dosage Prediction Model Development

Not Applicable

Conditions: NAT2 Genotype

Interventions: Genetic: genotype

First Posted Date: 2016-04-22

Last Posted Date: 2016-04-22

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 200

Registration Number: NCT02747654

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Anticoagulation in Cancer Related Stroke

Conditions: Cancer
Stroke

First Posted Date: 2016-04-19

Last Posted Date: 2016-04-19

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 400

Registration Number: NCT02743052

Locations: 🇰🇷
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy